Related references
Note: Only part of the references are listed.Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria
Anem Waheed et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Elizabeta Nemeth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Erythropoietic regulators of iron metabolism
Tomas Ganz
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria
Antonio M. Risitano et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Paroxysmal nocturnal haemoglobinuria
Anita Hill et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver
Igor Theurl et al.
NATURE MEDICINE (2016)
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging
Antonio M. Risitano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena
Alexander Roeth et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation
Paul C. Adams et al.
JOURNAL OF HEPATOLOGY (2011)
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
Antonio M. Risitano et al.
BLOOD (2009)
Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin
Ivana De Domenico et al.
EMBO JOURNAL (2007)
Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin
Sara Gardenghi et al.
BLOOD (2007)
Share Paper
